The latest news in rare cancer tumour types including sarcomas
ESMO 2021: Tyrosine kinase inhibitor prolongs progression-free survival in rare neuroendocrine tumour
The first randomised study in malignant pheochromocytoma and paraganglioma (MPP) has found that sunitinib prolongs…